Us Bancorp \De\ Jounce Therapeutics, Inc. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 01, 2018	SELL	$6.5 - $8.37 $455 - $585	-70 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$7.27 - $21.88 $508 - $1,531	70 New	70 $1,000
Q1 2018 May 08, 2018	SELL	$13.4 - $28.4 $19,537 - $41,407	-1,458 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$12.52 - $17.82 $425 - $605	34 Added 2.39%	1,458 $18,000
Q3 2017 Nov 13, 2017	BUY	$11.17 - $16.99 $15,906 - $24,193	1,424	1,424 $23,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.